1. Home
  2. EXPO vs RCUS Comparison

EXPO vs RCUS Comparison

Compare EXPO & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Exponent Inc.

EXPO

Exponent Inc.

HOLD

Current Price

$53.69

Market Cap

3.1B

ML Signal

HOLD

Logo Arcus Biosciences Inc.

RCUS

Arcus Biosciences Inc.

HOLD

Current Price

$23.77

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EXPO
RCUS
Founded
1967
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
2.8B
IPO Year
1996
2018

Fundamental Metrics

Financial Performance
Metric
EXPO
RCUS
Price
$53.69
$23.77
Analyst Decision
Buy
Buy
Analyst Count
3
10
Target Price
$88.00
$31.90
AVG Volume (30 Days)
433.8K
1.2M
Earning Date
04-30-2026
05-05-2026
Dividend Yield
1.87%
N/A
EPS Growth
N/A
N/A
EPS
0.59
N/A
Revenue
$582,014,000.00
$247,000,000.00
Revenue This Year
$12.75
N/A
Revenue Next Year
$8.50
$45.62
P/E Ratio
$91.24
N/A
Revenue Growth
4.21
N/A
52 Week Low
$51.91
$7.92
52 Week High
$81.95
$28.72

Technical Indicators

Market Signals
Indicator
EXPO
RCUS
Relative Strength Index (RSI) 17.88 46.31
Support Level N/A $20.20
Resistance Level $69.96 $24.33
Average True Range (ATR) 2.43 1.21
MACD -1.29 -0.24
Stochastic Oscillator 10.95 4.24

Price Performance

Historical Comparison
EXPO
RCUS

About EXPO Exponent Inc.

Exponent Inc is a science and engineering consulting firm that provides solutions to complex problems. The company's consultant team is composed of scientists, physicians, engineers, as well as business and regulatory consultants. The company currently operates through two segments. The engineering and other scientific segments, which account for the majority of revenue, provide servicing encompassing biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, etc. The environmental and health segment covers chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences and others. The company generates almost all of its revenues from America.

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

Share on Social Networks: